SEMAGLUTIDE 20MG | GLP-1 Obesity Research

Semaglutide 20mg is a research-grade GLP-1 receptor agonist studied for appetite control, weight reduction, insulin sensitivity and cardiometabolic endpoints. This 3 ml vial containing 20 mg presentation is intended for laboratory investigation of higher-exposure GLP-1 receptor studies. Semaglutide is a fatty-acylated GLP-1 analog that activates the GLP-1 receptor with a week-long half-life. Its effects include glucose-dependent insulin secretion, glucagon suppression, delayed gastric emptying and reduced food intake via hypothalamic POMC and CART neurons.

Higher exposures are studied for their effects on body weight, liver fat and cardiovascular risk markers. Wilding and colleagues (New England Journal of Medicine, 2021) reported approximately 15% mean weight loss with semaglutide 2.4 mg in STEP 1. The SELECT trial later showed a reduction in major adverse cardiovascular events in adults with overweight or obesity and established cardiovascular disease. The 20 mg presentation supports chronic dosing studies, multi-organ endpoint panels and comparisons with tirzepatide and retatrutide.

Researchers measure body composition, glucose tolerance, lipid profiles and inflammatory markers. Because higher exposures increase gastrointestinal effects, protocols should use gradual titration and pair-fed controls. Reconstitute freshly, keep the solution cold, and verify concentration before dosing to avoid inadvertent over- or under-exposure. For long-term storage, keep the lyophilised vial desiccated at -20C and allow it to equilibrate to room temperature before opening to prevent condensation. Reconstitute with bacteriostatic water, mix gently, and avoid vortexing or repeated freeze-thaw cycles.

Open questions include the mechanism of cardiovascular benefit, the long-term effect on lean mass and bone, and whether intermittent dosing can maintain efficacy with fewer side effects. For research use only. This material is not a drug, food or cosmetic and must not be administered to humans or animals outside an approved research protocol.